■大麻二酚(CBD)显示出各种适应症的希望,包括焦虑。先前的调查工作表明,焦虑是人们使用大麻二酚(CBD)的首要原因,但没有工作评估个人使用CBD专门为焦虑。
■当前的研究评估了81名参与者(Mage=32.63,SDage=12.99)的CBD产品使用模式和看法,他们报告在过去30天内使用CBD产品与焦虑相关的问题。
■家人和朋友,其次是流行和科学文献,是告知参与者决定使用CBD产品瞄准焦虑的最常见来源。平均而言,参与者报告称每天使用CBD产品至少1年,并表示其在针对焦虑相关症状方面非常有效.CBD产品改善的前三名症状是主观焦虑,入睡困难,和烦躁。这些发现是尽管最常见的剂量水平(〜50mg)远低于经验观察到的抗焦虑作用。大多数参与者否认有副作用,增加支持CBD产品的安全性和耐受性的文献。最后,参与者通常对CBD产品的性质知之甚少(例如,与THC的区别),这表明需要对消费者进行教育。
■集体,当前的研究扩展了先前的调查工作,表明人们对CBD产品的强烈期望,特别是在减少焦虑方面,包括那些用它来瞄准焦虑相关症状的人。研究结果还强调了解决科学知识和消费者知识之间差距的重要性。
UNASSIGNED: Cannabidiol (CBD) shows promise for a variety of indications, including anxiety. Prior survey work indicates anxiety ranks as a top reason for which people use cannabidiol (CBD), but no work has evaluated individuals using CBD specifically for anxiety.
UNASSIGNED: The current study evaluated CBD product use patterns and perceptions within a sample of 81 participants (Mage = 32.63, SDage = 12.99) who reported using CBD products for anxiety-related concerns within the past 30 days.
UNASSIGNED: Family and friends, followed by popular and scientific literature, were the most common sources informing participants\' decision to use CBD products to target anxiety. On average, participants reported using CBD products daily for at least a year and indicated it was very effective in targeting anxiety-related symptoms. The top three ranked symptoms improved by CBD products were subjective anxiety, difficulty falling asleep, and irritability. These findings were despite the fact that the most frequent dosing levels (∼50mg) were well below those empirically observed to yield anxiolytic effects. Most participants denied side effects, adding to the literature supporting CBD products\' safety and tolerability. Finally, participants were generally poorly informed about the nature of CBD products (e.g., distinction from THC), suggesting a need for consumer education.
UNASSIGNED: Collectively, the current study extends prior survey work suggesting powerful expectancies about CBD products, particularly in terms of anxiety reduction, including among those using it to target anxiety-related symptoms. Findings also highlight the importance of addressing the gap between scientific and consumer knowledge.